BioCentury | Dec 2, 2020
Finance

Canbridge broadens investor syndicate with $43M series E

...a pipeline of therapies for rare diseases in China.Returning investors in the series E round included Hudson Bay Capital Management...
BioCentury | Apr 4, 2020
Finance

Megarounds for Chinese biopharmas Legend, RemeGen to support late-stage push

...SEC review (see “GenScript Planning to Spin Out CAR T Unit Legend” ). New investors Hudson Bay Capital Management...
BioCentury | May 19, 2014
Company News

MabVax, Telik deal

...on the board. In support of the merger, a group of private investors led by Hudson Bay Capital Management...
Items per page:
1 - 3 of 3
BioCentury | Dec 2, 2020
Finance

Canbridge broadens investor syndicate with $43M series E

...a pipeline of therapies for rare diseases in China.Returning investors in the series E round included Hudson Bay Capital Management...
BioCentury | Apr 4, 2020
Finance

Megarounds for Chinese biopharmas Legend, RemeGen to support late-stage push

...SEC review (see “GenScript Planning to Spin Out CAR T Unit Legend” ). New investors Hudson Bay Capital Management...
BioCentury | May 19, 2014
Company News

MabVax, Telik deal

...on the board. In support of the merger, a group of private investors led by Hudson Bay Capital Management...
Items per page:
1 - 3 of 3